207 related articles for article (PubMed ID: 8103663)
1. delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.
Bonnin A; Fernández-Ruiz JJ; Martín M; Rodríguez de Fonseca F; Hernández ML; Ramos JA
J Neural Transm Gen Sect; 1993; 92(2-3):81-95. PubMed ID: 8103663
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic modulation of delta(9)-Tetrahydrocannabinol effects on nigrostriatal dopaminergic activity in the female rat brain.
Bonnin A; Ferández-Ruiz JJ; Martín M; De Fonseca FR; De Miguel R; Ramos JA
Mol Cell Neurosci; 1992 Aug; 3(4):315-25. PubMed ID: 19912874
[TBL] [Abstract][Full Text] [Related]
3. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.
Navarro M; Fernández-Ruiz JJ; de Miguel R; Hernández ML; Cebeira M; Ramos JA
Behav Brain Res; 1993 Oct; 57(1):37-46. PubMed ID: 8292253
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement.
Rodríguez de Fonseca F; Cebeira M; Ramos JA; Martín M; Fernández-Ruiz JJ
Life Sci; 1994; 54(3):159-70. PubMed ID: 8289577
[TBL] [Abstract][Full Text] [Related]
5. Possible role of the cytochrome P450-linked monooxygenase system in preventing delta 9-tetrahydrocannabinol-induced stimulation of tuberoinfundibular dopaminergic activity in female rats.
Bonnin A; de Miguel R; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Biochem Pharmacol; 1994 Oct; 48(7):1387-92. PubMed ID: 7945437
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.
Rodríguez De Fonseca F; Fernández-Ruiz JJ; Murphy LL; Cebeira M; Steger RW; Bartke A; Ramos JA
Pharmacol Biochem Behav; 1992 Jun; 42(2):269-75. PubMed ID: 1321451
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
Bonnin A; Ramos JA; Rodríguez de Fonseca F; Cebeira M; Fernández-Ruiz JJ
Neuroendocrinology; 1993 Sep; 58(3):280-6. PubMed ID: 7902959
[TBL] [Abstract][Full Text] [Related]
8. Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain.
Fernández-Ruiz JJ; de Miguel R; Hernández ML; Ramos JA
Pharmacol Biochem Behav; 1990 Jul; 36(3):603-6. PubMed ID: 2377660
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.
Rodríguez de Fonseca F; Gorriti MA; Fernández-Ruiz JJ; Palomo T; Ramos JA
Pharmacol Biochem Behav; 1994 Jan; 47(1):33-40. PubMed ID: 8115426
[TBL] [Abstract][Full Text] [Related]
10. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.
García-Gil L; De Miguel R; Muñoz RM; Cebeira M; Villanua MA; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1997; 19(6):477-87. PubMed ID: 9392783
[TBL] [Abstract][Full Text] [Related]
11. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
[TBL] [Abstract][Full Text] [Related]
12. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
Mickley KR; Dluzen DE
Neuroendocrinology; 2004; 79(6):305-16. PubMed ID: 15256808
[TBL] [Abstract][Full Text] [Related]
13. Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.
Hernández ML; Fernández-Ruiz JJ; Navarro M; de Miguel R; Cebeira M; Vaticón L; Ramos JA
J Neural Transm Gen Sect; 1994; 96(1):63-79. PubMed ID: 7857592
[TBL] [Abstract][Full Text] [Related]
14. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats.
Navarro M; de Miguel R; Rodríguez de Fonseca F; Ramos JA; Fernández-Ruiz JJ
Behav Brain Res; 1996 Feb; 75(1-2):91-8. PubMed ID: 8800663
[TBL] [Abstract][Full Text] [Related]
15. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
González S; Bisogno T; Wenger T; Manzanares J; Milone A; Berrendero F; Di Marzo V; Ramos JA; Fernández-Ruiz JJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):260-6. PubMed ID: 10733937
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels.
Cebeira M; Hernandez ML; Rodriguez de Fonseca F; de Miguel R; Fernandez-Ruiz JJ; Ramos JA
Life Sci; 1991; 48(6):531-41. PubMed ID: 1671524
[TBL] [Abstract][Full Text] [Related]
18. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
[TBL] [Abstract][Full Text] [Related]
19. Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs.
García L; de Miguel R; Ramos JA; Fernàndez-Ruiz JJ
Drug Alcohol Depend; 1996 Nov; 42(3):155-66. PubMed ID: 8912798
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats.
Rodríguez de Fonseca FR; Villanúa MA; Muñoz RM; San-Martin-Clark O; Navarro M
Neuroendocrinology; 1995 Jun; 61(6):714-21. PubMed ID: 7659195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
